Seoul Pharma Co. Ltd Market Cap ($13.42 Million)

$13.42 Million USD · ₩19.81 Billion KRW · Rank #26152

Market Cap & Net Worth: Seoul Pharma Co. Ltd (018680)

Seoul Pharma Co. Ltd market cap. Seoul Pharma Co. Ltd (KQ:018680) has a market capitalization of $13.42 Million (₩19.81 Billion) as of November 6, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #26152 globally and #1958 in its home market, demonstrating a -10.53% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Seoul Pharma Co. Ltd's stock price ₩1699.00 by its total outstanding shares 11659319 (11.66 Million). Also see 018680 cash flow metrics for how efficiently the company converts equity into cash flow.

Seoul Pharma Co. Ltd Market Cap History (2015–2026)

Seoul Pharma Co. Ltd market cap history from 2015 to 2026. Data shows change from $119.28 Million to $13.42 Million (-18.53% CAGR). Check 018680 share price today for real-time trading data and today's change.

Index Memberships

Seoul Pharma Co. Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$207.23 Billion	0.01%	#1063 of 1384
Kosdaq Composite Index KQ11	$207.23 Billion	0.01%	#1063 of 1384

Weight: Seoul Pharma Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Seoul Pharma Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Seoul Pharma Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 018680 net assets growth trend to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.00x

Seoul Pharma Co. Ltd's market cap is 0.00 times its annual revenue

Industry average: 0.59x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.02x

Seoul Pharma Co. Ltd's market cap is 0.02 times its annual earnings

Industry average: 13.94x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2015	$119.28 Million	$44.73 Billion	-$783.06 Million	0.00x	N/A
2016	$72.94 Million	$45.92 Billion	$816.80 Million	0.00x	0.09x
2017	$86.19 Million	$46.65 Billion	$881.44 Million	0.00x	0.10x
2018	$45.50 Million	$44.14 Billion	-$4.35 Billion	0.00x	N/A
2019	$53.26 Million	$53.95 Billion	-$1.87 Billion	0.00x	N/A
2020	$86.52 Million	$52.23 Billion	-$1.34 Billion	0.00x	N/A
2021	$62.03 Million	$40.46 Billion	-$9.69 Billion	0.00x	N/A
2022	$39.74 Million	$50.06 Billion	$855.09 Million	0.00x	0.05x
2023	$30.26 Million	$52.46 Billion	$3.52 Billion	0.00x	0.01x
2024	$26.15 Million	$53.58 Billion	$1.70 Billion	0.00x	0.02x

Competitor Companies of 018680 by Market Capitalization

Companies near Seoul Pharma Co. Ltd in the global market cap rankings as of November 6, 2026. Also see how large is Seoul Pharma Co. Ltd's balance sheet for a full breakdown of the balance sheet.

Key companies related to Seoul Pharma Co. Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#514	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#538	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$47.80
#588	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.79 Billion	CN¥49.05
#621	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.50

Market Capitalization of Seoul Pharma Co. Ltd (2015–2026)

Market capitalization of Seoul Pharma Co. Ltd from 2015 to today. Between 2015 and today, Seoul Pharma Co. Ltd's market cap moved from $119.28 Million to $ 13.42 Million, with a yearly change of -18.53%.

Year	Market Cap	Change (%)
2026	₩13.42 Million	-44.84%
2025	₩24.34 Million	-6.95%
2024	₩26.15 Million	-13.58%
2023	₩30.26 Million	-23.86%
2022	₩39.74 Million	-35.92%
2021	₩62.03 Million	-28.31%
2020	₩86.52 Million	+62.46%
2019	₩53.26 Million	+17.05%
2018	₩45.50 Million	-47.21%
2017	₩86.19 Million	+18.17%
2016	₩72.94 Million	-38.85%
2015	₩119.28 Million	--

End of Day Market Cap According to Different Sources

On Nov 5th, 2026 the market cap of Seoul Pharma Co. Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$13.42 Million USD
MoneyControl	$13.42 Million USD
MarketWatch	$13.42 Million USD
marketcap.company	$13.42 Million USD
Reuters	$13.42 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Seoul Pharma Co. Ltd

KQ:018680 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$13.42 Million

₩19.81 Billion KRW

Market Cap Rank

#26152 Global

#1958 in Korea

Share Price

₩1699.00

Change (1 day)

-0.35%

52-Week Range

₩1687.00 - ₩3165.00

All Time High

₩17976.69